Q32 Bio (QTTB) Cash from Financing Activities (2017 - 2026)

Q32 Bio's Cash from Financing Activities history runs 10 years deep, the most recent figure standing at $8.8 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities changed N/A year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $6.0 million (changed N/A YoY), while the FY2025 annual figure was -$3.1 million, down 103.28% from the prior year.
• Cash from Financing Activities was $8.8 million for Q1 2026 at Q32 Bio, up from -$1.6 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $99.3 million in Q1 2024 to a low of -$5.5 million in Q2 2024.
• Historically, Cash from Financing Activities has averaged $7.3 million across 5 years, with a median of $100000.0 in 2022.
• Biggest YoY gain for Cash from Financing Activities was 662206.67% in 2024; the steepest drop was 36913.33% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at $32000.0 in 2022, then surged by 137.5% to $76000.0 in 2023, then surged by 317.11% to $317000.0 in 2024, then tumbled by 592.74% to -$1.6 million in 2025, then soared by 663.19% to $8.8 million in 2026.
• The last three Cash from Financing Activities figures came in at $8.8 million (Q1 2026), -$1.6 million (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.